Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population pharmacokinetics of liposomal amphotericin B and caspofungin in allogeneic hematopoietic stem cell recipients.
Würthwein G, Young C, Lanvers-Kaminsky C, Hempel G, Trame MN, Schwerdtfeger R, Ostermann H, Heinz WJ, Cornely OA, Kolve H, Boos J, Silling G, Groll AH. Würthwein G, et al. Among authors: silling g. Antimicrob Agents Chemother. 2012 Jan;56(1):536-43. doi: 10.1128/AAC.00265-11. Epub 2011 Nov 14. Antimicrob Agents Chemother. 2012. PMID: 22083471 Free PMC article. Clinical Trial.
Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients.
Groll AH, Silling G, Young C, Schwerdtfeger R, Ostermann H, Heinz WJ, Gerss J, Kolve H, Lanvers-Kaminsky C, Vieira Pinheiro JP, Gammelin S, Cornely OA, Wuerthwein G. Groll AH, et al. Among authors: silling g. Antimicrob Agents Chemother. 2010 Oct;54(10):4143-9. doi: 10.1128/AAC.00425-10. Epub 2010 Jul 26. Antimicrob Agents Chemother. 2010. PMID: 20660670 Free PMC article. Clinical Trial.
Phase II dose escalation study of caspofungin for invasive Aspergillosis.
Cornely OA, Vehreschild JJ, Vehreschild MJ, Würthwein G, Arenz D, Schwartz S, Heussel CP, Silling G, Mahne M, Franklin J, Harnischmacher U, Wilkens A, Farowski F, Karthaus M, Lehrnbecher T, Ullmann AJ, Hallek M, Groll AH. Cornely OA, et al. Among authors: silling g. Antimicrob Agents Chemother. 2011 Dec;55(12):5798-803. doi: 10.1128/AAC.05134-11. Epub 2011 Sep 12. Antimicrob Agents Chemother. 2011. PMID: 21911573 Free PMC article. Clinical Trial.
Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry.
Vehreschild JJ, Sieniawski M, Reuter S, Arenz D, Reichert D, Maertens J, Böhme A, Silling G, Martino R, Maschmeyer G, Rüping MJ, Ullmann AJ, Cornely OA. Vehreschild JJ, et al. Among authors: silling g. Int J Antimicrob Agents. 2009 Nov;34(5):446-50. doi: 10.1016/j.ijantimicag.2009.06.025. Epub 2009 Aug 22. Int J Antimicrob Agents. 2009. PMID: 19700265 Free article.
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients.
Glasmacher A, Cornely OA, Orlopp K, Reuter S, Blaschke S, Eichel M, Silling G, Simons B, Egerer G, Siemann M, Florek M, Schnitzler R, Ebeling P, Ritter J, Reinel H, Schütt P, Fischer H, Hahn C, Just-Nuebling G. Glasmacher A, et al. Among authors: silling g. J Antimicrob Chemother. 2006 Jan;57(1):127-34. doi: 10.1093/jac/dki410. Epub 2005 Nov 24. J Antimicrob Chemother. 2006. PMID: 16308418 Clinical Trial.
Forty-one recent cases of invasive zygomycosis from a global clinical registry.
Rüping MJ, Heinz WJ, Kindo AJ, Rickerts V, Lass-Flörl C, Beisel C, Herbrecht R, Roth Y, Silling G, Ullmann AJ, Borchert K, Egerer G, Maertens J, Maschmeyer G, Simon A, Wattad M, Fischer G, Vehreschild JJ, Cornely OA. Rüping MJ, et al. Among authors: silling g. J Antimicrob Chemother. 2010 Feb;65(2):296-302. doi: 10.1093/jac/dkp430. Epub 2009 Dec 11. J Antimicrob Chemother. 2010. PMID: 20008047
Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.
Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, Elias J, Haase G, Hahn-Ast C, Karthaus M, Kekulé A, Keller P, Kiehl M, Krause SW, Krämer C, Neumann S, Rohde H, La Rosée P, Ruhnke M, Schafhausen P, Schalk E, Schulz K, Schwartz S, Silling G, Staib P, Ullmann A, Vergoulidou M, Weber T, Cornely OA, Vehreschild MJ. Koehler P, et al. Among authors: silling g. Int J Antimicrob Agents. 2017 Feb;49(2):218-223. doi: 10.1016/j.ijantimicag.2016.10.019. Epub 2016 Dec 12. Int J Antimicrob Agents. 2017. PMID: 27989379 Clinical Trial.
76 results